Assessing the Ankylosing Spondylitis Performance Index in Young Patients with Arthritis
The Reliability and Validity of the Ankylosing Spondylitis Performance Index (ASPI) Physical Function Test in Enthesitis-Related Arthritis
This study is testing a new way to measure how well children and teens with arthritis can move and function to see if it helps track their condition better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 7 Years to 18 Years |
| Sex | All |
| Sponsor | Hacettepe University Academic / other |
| Locations | 1 site (Ankara) |
| Trial ID | NCT06383195 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the reliability and validity of the Ankylosing Spondylitis Performance Index (ASPI) in measuring physical function in children and adolescents diagnosed with Enthesitis-related arthritis (ERA). The ASPI combines three performance tests to provide objective insights into patients' physical capabilities, which is crucial for tracking disease progression and treatment effectiveness. By focusing on a population that often experiences significant physical limitations, the study aims to enhance the assessment tools available for this condition.
Who should consider this trial
Good fit: Ideal candidates for this study are children and adolescents aged 7-18 who have been diagnosed with Enthesitis-Related Arthritis.
Not a fit: Patients with advanced organ diseases, major orthopedic surgery history, or severe mental health issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved assessment methods for physical functionality in young patients with ERA, ultimately guiding better treatment strategies.
How similar studies have performed: While the ASPI has been developed for adult patients, this application in a juvenile population is relatively novel and has not been extensively tested in similar studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being diagnosed with Enthesitis-Related Arthritis (ERA) according to The International League of Associations for Rheumatology (ILAR) classification * Being between the ages of 7-18 * Volunteering to participate in research Exclusion Criteria: * Advanced heart/lung/liver/kidney disease, neurological disease and malignancies * Having undergone major orthopedic surgery * The presence of moderate to severe mental problems that will negatively affect participation * Not volunteering to participate in the study
Where this trial is running
Ankara
- Hacettepe University — Ankara, Turkey (Recruiting)
Study contacts
- Principal investigator: Sinan Buran, RA — Hacettepe University Faculty of Physical Therapy and Rehabilitation
- Study coordinator: Sinan Buran, RA
- Email: pt.sinanburan@gmail.com
- Phone: +903123052525
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.